chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Heart rate irregular, Hyperhidrosis, Lethargy, Myalgia
Clinical narrative: Fever; Muscle aches; Pains; Sensitivity to light; Nausea; Chills; Sweats; Overall lethargy; Irregular heart rate; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203), via an unspecified route of administration in right arm on 16Mar2021 at 14:30 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took cefalexin (KELFLEX) and amoxicillin; clavulanic acid (AUGMENTIN) and experienced drug allergy on an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021 at 23:45, the patient experienced fever, muscle aches, pains, sensitivity to light, nausea, chills, sweats, overall lethargy, irregular heart rate. The patient did not receive any treatment for the reported events. The clinical outcome of the fever, muscle aches, pains, sensitivity to light, nausea, chills, sweats, overall lethargy, irregular heart rate was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Photophobia, Pyrexia
Clinical narrative: Fever; Muscle aches; Pains; Sensitivity to light; Nausea; Chills; Sweats; Overall lethargy; Irregular heart rate; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203), via an unspecified route of administration in right arm on 16Mar2021 at 14:30 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took cefalexin (KELFLEX) and amoxicillin; clavulanic acid (AUGMENTIN) and experienced drug allergy on an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021 at 23:45, the patient experienced fever, muscle aches, pains, sensitivity to light, nausea, chills, sweats, overall lethargy, irregular heart rate. The patient did not receive any treatment for the reported events. The clinical outcome of the fever, muscle aches, pains, sensitivity to light, nausea, chills, sweats, overall lethargy, irregular heart rate was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Pyrexia
Clinical narrative: extreme fatigue; Hot sweats and chills mild fever; Hot sweats and chills mild fever; Hot sweats and chills mild fever of 101.1; Headache; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Batch number: EN6205) via an unspecified route of administration in the left arm on 16Mar2021 at 19:30 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Batch number: EN6198) via an unspecified route of administration in the right arm on 26Feb2021 at 19:30, as a single dose for COVID-19 immunisation. The patient medical history was not reported. The patient did not received any other medications within 2 weeks of vaccination. The patient did not have any allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. The patient experienced extreme fatigue, Hot sweats and chills mild fever of 101.1 and headache on 17Mar2021. The patient did not receive treatment for the reported event. The clinical outcome of the fatigue extreme, sweating, chills, fever and headache was unknown. No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Headache; Chills; Fatigue; This is a spontaneous report received from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 16Mar2021 at 10:30 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included vitamin D3 (MANUFACTURER UNKNOWN), multivitamin (MANUFACTURER UNKNOWN) and probiotic (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Mar2021 at 11:00, the patient experienced headache, chills and fatigue. The patient did not receive any treatment for the adverse events. The clinical outcome of the events headache, chills and fatigue was recovering.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Dry throat, Lip dry, Lip pruritus, Oral pruritus
Clinical narrative: Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Tight throat and tongue some minimal; Tight throat and tongue some minimal; Swelling in tongue and throat.; Swelling in tongue and throat.; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old, non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in left arm on 17Mar2021 at 08:30 (age of vaccination 44-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication includes vitamins C (MANUFACTURER UNKNOWN), b12 (MANUFACTURER UNKNOWN), multi vit (not coded) (MANUFACTURER UNKNOWN), omega 3 (MANUFACTURER UNKNOWN), all for an unknown indication since an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient took aspirin in the past and experienced drug allergy. On 17Mar2021 at 09:15, the patient experienced dry, itchy throat, lips, mouth and tongue, tight throat and tongue and some minimal swelling in tongue and throat. No therapeutic measures were taken for the adverse event. The clinical outcome for the events dry itchy throat, lips, mouth and tongue, tight throat and tongue some minimal swelling in tongue and throat was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Stiff tongue, Swollen tongue, Throat irritation, Throat tightness
Clinical narrative: Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Tight throat and tongue some minimal; Tight throat and tongue some minimal; Swelling in tongue and throat.; Swelling in tongue and throat.; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old, non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in left arm on 17Mar2021 at 08:30 (age of vaccination 44-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication includes vitamins C (MANUFACTURER UNKNOWN), b12 (MANUFACTURER UNKNOWN), multi vit (not coded) (MANUFACTURER UNKNOWN), omega 3 (MANUFACTURER UNKNOWN), all for an unknown indication since an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient took aspirin in the past and experienced drug allergy. On 17Mar2021 at 09:15, the patient experienced dry, itchy throat, lips, mouth and tongue, tight throat and tongue and some minimal swelling in tongue and throat. No therapeutic measures were taken for the adverse event. The clinical outcome for the events dry itchy throat, lips, mouth and tongue, tight throat and tongue some minimal swelling in tongue and throat was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Tongue dry, Tongue pruritus
Clinical narrative: Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Dry, ichy throat, lips, mouth and tongue; Tight throat and tongue some minimal; Tight throat and tongue some minimal; Swelling in tongue and throat.; Swelling in tongue and throat.; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old, non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in left arm on 17Mar2021 at 08:30 (age of vaccination 44-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication includes vitamins C (MANUFACTURER UNKNOWN), b12 (MANUFACTURER UNKNOWN), multi vit (not coded) (MANUFACTURER UNKNOWN), omega 3 (MANUFACTURER UNKNOWN), all for an unknown indication since an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient took aspirin in the past and experienced drug allergy. On 17Mar2021 at 09:15, the patient experienced dry, itchy throat, lips, mouth and tongue, tight throat and tongue and some minimal swelling in tongue and throat. No therapeutic measures were taken for the adverse event. The clinical outcome for the events dry itchy throat, lips, mouth and tongue, tight throat and tongue some minimal swelling in tongue and throat was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Insomnia, Muscle spasms
Clinical narrative: Debilitating leg cramps; Could barely walk; Could not sleep; This is a spontaneous report received from a contactable consumer, the patient. A 57-year-old non pregnant female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (Lot no: I 6198) via an unspecified route of administration in the left arm on 16Mar2021 at 08:30 hours (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. Concomitant medications included unspecified medications for unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021 about 20:00 hours, the patient experienced debilitating leg cramps until 17Mar2021 12:00. On the same day, the patient could not sleep and could barely. The clinical outcome of the event debilitating leg cramps was recovered on 17Mar2021 12:00 and for the events could barely walk and could not sleep was reported as resolving. No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling hot, Flushing, Heart rate, Heart rate increased
Clinical narrative: Slightly lightheaded; Slight ringing in my ears; Resting heart rate began to increase; Facial/neck flushing; Became hot; This is a spontaneous report from a contactable nurse, the patient. A 40-year-old non-pregnant female patient received first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6200), via an unspecified route of administration on the left arm on 17Mar2021 at 14:15 (at the age of 40-year-old) for COVID-19 immunisation. Concomitant medications (within 2 weeks of vaccination) included vitamin E, hydrolyzed collagen, vitamin C, biotin. She has no known allergies to any medications, food, or other products. She did not receive any other vaccines within 4 weeks prior to the covid-19 vaccine and was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, she had not tested positive for COVID-19. On 17Mar2021 (within 2-3 minutes after the vaccination), she became slightly lightheaded with a slight ringing in her ears; Her resting heart rate began to increase from 70 beats per minute up to 131 beats per minute with facial/neck flushing and she also became hot. The symptoms resolved within the next 2-3 minutes. It was also confirmed that she was 5 hours out from receiving the vaccine without further issue. No therapeutic measures were taken to treat these events. The clinical outcome for the events became hot, facial/neck flushing, resting heart rate began to increase, slightly lightheaded, slight ringing in her ears was recovered on the same day (17Mar2021). No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Slightly lightheaded; Slight ringing in my ears; Resting heart rate began to increase; Facial/neck flushing; Became hot; This is a spontaneous report from a contactable nurse, the patient. A 40-year-old non-pregnant female patient received first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6200), via an unspecified route of administration on the left arm on 17Mar2021 at 14:15 (at the age of 40-year-old) for COVID-19 immunisation. Concomitant medications (within 2 weeks of vaccination) included vitamin E, hydrolyzed collagen, vitamin C, biotin. She has no known allergies to any medications, food, or other products. She did not receive any other vaccines within 4 weeks prior to the covid-19 vaccine and was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, she had not tested positive for COVID-19. On 17Mar2021 (within 2-3 minutes after the vaccination), she became slightly lightheaded with a slight ringing in her ears; Her resting heart rate began to increase from 70 beats per minute up to 131 beats per minute with facial/neck flushing and she also became hot. The symptoms resolved within the next 2-3 minutes. It was also confirmed that she was 5 hours out from receiving the vaccine without further issue. No therapeutic measures were taken to treat these events. The clinical outcome for the events became hot, facial/neck flushing, resting heart rate began to increase, slightly lightheaded, slight ringing in her ears was recovered on the same day (17Mar2021). No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Hypoaesthesia, Pain in extremity
Clinical narrative: Left-sided facial numbness; Left-sided headache; Left arm ache; Shoulder ache; This is a spontaneous report received from a contactable consumer, the patient. An elderly female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unknown route of administration in the left arm on 17Mar2021 at 13:00 hours as a single dose for COVID-19 immunisation. The Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included calcium supplement (MANUFACTURER UNKNOWN) and multivitamins (MANUFACTURER UNKNOWN). The patient received these medications within 2 weeks of vaccination and exact therapy dates for these medications were not reported. On 17Mar2021 at 15:30 hours, after receiving the first dose of vaccine in her left upper arm, the patient felt left-sided facial numbness as if patient had a dental Novocaine injection. In addition, the patient had left-sided headache, left arm and shoulder ache. The clinical outcome of the events left-sided facial numbness, left-sided headache, left arm ache and shoulder ache was not resolved.   No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: Pain seems to come from injection site, then into the shoulder joint and sometimes travels to the elbow and forearm; Pain in the left arm; This is a spontaneous report received from a contactable consumer, the patient. A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: EP- EN6202) via an unspecified route of administration on the left arm on 03Mar2021 at 14:30 (at the age of 67-year-old) as a single dose for Covid-19 immunisation. The patient medical history included hypertension. The patient was allergic to amoxicillin and NSAIDS. The patient concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 12Mar2021, the patient experienced pain in the left arm which seemed to have come from injection site, then moved into the shoulder joint and sometimes travelled to the elbow and forearm. This pain began in the late afternoon and continued through the night but it was absent most of the day. The patient did not receive any treatment for the reported events. The clinical outcome for the events pain in the left arm, pain seems to come from injection site, then into the shoulder joint and sometimes travels to the elbow and forearm were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: Rapid heart rate; This is a spontaneous report from a contactable consumer, the patient. A 60 Years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE (Lot number: Er 2613) via an unspecified route of administration in left arm on 17Mar2021at 1600, as single dose for COVID-19 immunisation. The patients medical history and concomitant medications were not reported.  Patients past drug history included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE (Lot number: EN6198) via unspecified route of administration in left arm on 24Mar2021 at 1645, as a single dose for COVID 19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19, Since the vaccination had not been tested for COVID-19.   On 17Mar2021at 1730, the patient experienced rapid heart rate with 100 bpm. The patient did not receive any treatment for the event. Clinical outcome of rapid heart rate was recovering at the time of reporting.  No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lip swelling, Oropharyngeal pain, Swollen tongue
Clinical narrative: Upper lip swollen; tongue swollen; Very fatigue; sore throat; This is a spontaneous report from a contactable consumer, the patient. A 28-years-old female patient received second dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via an unspecified route of administration in the left arm on 15Mar2021 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient previously received a first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264) via an unspecified route of administration in the left arm on 24Feb2021 at 15:30 hours (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient had allergy to shellfish. Concomitant medication included Tylenol for an unknown indication. The patient did not receive any other vaccine within 4 weeks prior to the covid-19 vaccination. The patient had not diagnosed with covid-19 prior to vaccination. Since the vaccination, patient had not been tested for covid-19. On 16Mar2021, the patient experienced swelling of upper lip and tongue, sore throat and felt very fatigue. Therapeutic measured included as benadryl and tylenol for the reported events. Clinical outcome of the events upper lip and tongue swollen, very fatigue and sore throat were resolving at the time of report.   No follow-up attempts are needed and no further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Eye pain, Headache, Pain
Clinical narrative: ache in joints; tightness in chest; Headache; body aches; ache in eyes; This is a spontaneous report from a contactable consumer. An elderly patient of an unknown age and gender received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: En6204 Expiry date: UNKNOWN) via an unspeciied route of administration at left arm on 05Mar2021 12:00 as a single dose for COVID 19 immunization. The patient's past drug history included first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE); Lot no: EN5318 Expiry date UNKNOWN) via an unspecified route of administration at left arm on 12Feb2021 10:30 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not provided. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 05Mar2021 13:00 the patient experienced headache, ache in eyes, body aches, tightness in chest and ache in joints. The patient did not receive treatment for the adverse events. The outcome of the events was not recovered   Amendment(25May2021): This follow-up report is being submitted to amend previously reported information: reporter details, patient demographics and suspect drug details were update. Past drug details were added. Event details were updated.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives; This is a spontaneous report received from a contactable healthcare professional (patient) via COVID-19 Adverse Event.   A 36-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in left arm on 13Feb2021, at 12:15 (Lot Number: EL9266) as first dose and second dose via an unspecified route of administration, administered in left arm on 06Mar2021 (Lot Number: En6203), each as a single dose for covid-19 immunization, at the age of 36-years old.  The patient's medical history was not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine.  Since the vaccination, the patient had not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, has the patient has not been tested for COVID-19. Concomitant medications included valacyclovir taken for an unspecified indication, start and stop date were not reported.  The patient experienced hives, which was described by the patient as hives breaking out all over my body on 16Feb2021 with outcome of not recovered.  Details were as follows: Patient reported, it was intense in the about three weeks following the first shot, and it continued after his second shot. Patient reported he had developed hives in areas like armpits, scalp, groin, eyes, lips. No therapeutic measures were not taken for the event. The clinical outcome of hives was not recovered.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Breast swelling, Fatigue, Lymphadenopathy, Nausea
Clinical narrative: Swelling of right breast; Swelling around past surgical site on left foot; Severe swelling in lymph nodes of right armpit, right neck, right jaw; Fatigue; Nausea; Fever (101.5 F); This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via unspecified route of administration in right arm, on 14Mar2021 at 16:45 (at the age of 29-years-old as a single dose for COVID-19 immunisation. Medical history included asthma, allergies to peanuts, tree nuts, fish, shellfish, sesame, strawberry, mango, vanilla, insect stings and other environmental, also had allergies to medications iodine, penicillin, clindamycin, human papillomavirus (HPV) Vaccine and latex. The patient underwent surgery (unspecified). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medications included escitalopram 20mg (MANUFACTURER UNKNOWN) and cetirizine 10mg (MANUFACTURER UNKNOWN) these medications were used within 2 weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via unspecified route of administration in the right arm on 21Feb2021 as a single dose for COVID-19 Immunisation. On 15Mar2021 at 02:00 hours, the patient experienced severe swelling in lymph nodes of right armpit, right neck, right jaw, swelling of right breast, swelling around past surgical site on left foot, fever 101.5 degrees Fahrenheit, fatigue and nausea. No therapeutic measures were taken for the events. The clinical outcome for severe swelling in lymph nodes of right armpit, right neck, right jaw, swelling of right breast, swelling around past surgical site on left foot, fever (101.5 F), fatigue and nausea was not recovered. No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia
Clinical narrative: Swelling of right breast; Swelling around past surgical site on left foot; Severe swelling in lymph nodes of right armpit, right neck, right jaw; Fatigue; Nausea; Fever (101.5 F); This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via unspecified route of administration in right arm, on 14Mar2021 at 16:45 (at the age of 29-years-old as a single dose for COVID-19 immunisation. Medical history included asthma, allergies to peanuts, tree nuts, fish, shellfish, sesame, strawberry, mango, vanilla, insect stings and other environmental, also had allergies to medications iodine, penicillin, clindamycin, human papillomavirus (HPV) Vaccine and latex. The patient underwent surgery (unspecified). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medications included escitalopram 20mg (MANUFACTURER UNKNOWN) and cetirizine 10mg (MANUFACTURER UNKNOWN) these medications were used within 2 weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via unspecified route of administration in the right arm on 21Feb2021 as a single dose for COVID-19 Immunisation. On 15Mar2021 at 02:00 hours, the patient experienced severe swelling in lymph nodes of right armpit, right neck, right jaw, swelling of right breast, swelling around past surgical site on left foot, fever 101.5 degrees Fahrenheit, fatigue and nausea. No therapeutic measures were taken for the events. The clinical outcome for severe swelling in lymph nodes of right armpit, right neck, right jaw, swelling of right breast, swelling around past surgical site on left foot, fever (101.5 F), fatigue and nausea was not recovered. No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Neck pain
Clinical narrative: Neck pain on shot side like whiplash; Finger joints swollen; Full body muscle and joint pain/ shoulder muscle pain; Sinus pain; Injection site pain; Severe temple/forehead headache; Full body muscle and joint pain/ shoulder muscle pain; Strong fatigue; This is a spontaneous report received from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration on 16Mar2021 (at the age of 62-year-old) as single dose for COVID-19 immunisation. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot: EL9264), via an unspecified route of administration in the right arm on 23Feb2021 at 11:00 as a single dose for COVID-19 immunisation. Medical history included Arthritis, AVN (Avascular necrosis) left hip, tendonitis, high blood pressure, fibromyalgia. Patient was allergic to Penicillin. Concomitant medication included Ativan, Hydochlorothiazide (Manufacturer unknown), Valtrex, Wellbutrin and Zana (Manufacturer unknown) all for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Feb2021 at 20:00 hours the patient experienced finger joints swollen, full body muscle and joint aches, Injection site pain, shoulder muscle pain (like sprained), joint aches, neck pain on shot side like whiplash, severe temple or forehead headache, sinus pain, strong fatigue. Patient did not receive any treatment for reported events. Clinical outcome of the events finger joints swollen, full body muscle and joint aches, Injection site pain, shoulder muscle pain (like sprained), joint aches, neck pain on shot side like whiplash, severe temple or forehead headache, sinus pain, strong fatigue was not recovered/not resolved.   No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Sinus pain, Vaccination site pain
Clinical narrative: Neck pain on shot side like whiplash; Finger joints swollen; Full body muscle and joint pain/ shoulder muscle pain; Sinus pain; Injection site pain; Severe temple/forehead headache; Full body muscle and joint pain/ shoulder muscle pain; Strong fatigue; This is a spontaneous report received from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration on 16Mar2021 (at the age of 62-year-old) as single dose for COVID-19 immunisation. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot: EL9264), via an unspecified route of administration in the right arm on 23Feb2021 at 11:00 as a single dose for COVID-19 immunisation. Medical history included Arthritis, AVN (Avascular necrosis) left hip, tendonitis, high blood pressure, fibromyalgia. Patient was allergic to Penicillin. Concomitant medication included Ativan, Hydochlorothiazide (Manufacturer unknown), Valtrex, Wellbutrin and Zana (Manufacturer unknown) all for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Feb2021 at 20:00 hours the patient experienced finger joints swollen, full body muscle and joint aches, Injection site pain, shoulder muscle pain (like sprained), joint aches, neck pain on shot side like whiplash, severe temple or forehead headache, sinus pain, strong fatigue. Patient did not receive any treatment for reported events. Clinical outcome of the events finger joints swollen, full body muscle and joint aches, Injection site pain, shoulder muscle pain (like sprained), joint aches, neck pain on shot side like whiplash, severe temple or forehead headache, sinus pain, strong fatigue was not recovered/not resolved.   No follow-up attempts are possible. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Fatigue, Pain, Pyrexia
Clinical narrative: Back pain; Fever of 99.2; Aches all over; Fatigue; This is a spontaneous report received from a contactable consumer, the patient.  A 20-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER1741) via an unspecified route of administration in the left arm on 17Mar2021 at 18:15 hours (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination the patient was diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included hypertension, chronic migraines, depression anxiety disorder and allergy to penicillin and lisinopril. Concomitant medications included norgestimate (MANUFACTURER UNKNOWN) and TRI-SPRINTEC, NORVASC and EFFEEXOR for unknown indication from an unknown date. On 17Mar2021, the patient had blood temperature test results given as 99.2 (units unspecified). On 17Mar2021 at 19:00 hours, the patient experienced back pain, fever of 99.2 (unit and reference range was not provided), aches all over and fatigue. The patient did not receive treatment for the events. The clinical outcome of the events back pain, fever of 99.2, aches all over and fatigue was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia, Vaccination site pain
Clinical narrative: Generalized fatigue; Injection site soreness; Severe headache for 3-4 hours a few hours after injection; Slight chills; Fever; This is a spontaneous report from a contactable non-healthcare professional reporting for a patient. A 40-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via unspecified route of administration in right arm on 16Mar2021 at 16:15 (age at vaccination 40-years-old) for COVID-19 immunisation. Prior to the vaccination the patient was not diagnosed with COVID 19. Since the vaccination, the patient had not been tested for COVID-19. The patient had known allergic to seasonal, pet dander, mold and dust. Medical history included severe asthma. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included SINGULAIR, LEXAPRO, SYMBICORT, VENTOLIN and allergy medication. On 16Mar2021, at 18:00 the patient experienced severe headache for 3-4 hours a few hours after injection, slight chills and fever. On 17Mar2021 patient experienced generalized fatigue and injection site soreness. The patient did not receive any treatment for the reported events. The clinical outcome of severe headache, slight chills, fever, generalized fatigue and injection site soreness was recovering at the time of reporting.   No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Migraine, Musculoskeletal stiffness
Clinical narrative: Tired feeling; Joint pain; Vomiting; Shaky feeling; Migraine; Stiff neck; Slight headache; This is a spontaneous report received from a contactable healthcare professional, the patient. A 42-year-old non pregnant female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via an unspecified route of administration in the left arm on 17Mar2021 at 14:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines, hypothyroidism, tension headache (on 16Mar2021) and allergic to mold. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included SYNTHROID, ZYRTEC and MIDNITES, all for an unspecified indication, initiated on unknown date. The patient previously received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the left arm on 24Feb2021 at 14:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient previously took aspirin and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021, immediately after the vaccination, the patient experienced a bit of a stiff neck and still had a slight headache. Over the course of about 5 hours at 19:00, the headache turned into a migraine with splitting head pain, shaky feeling and vomiting. The patient was self-treated with two TYLENOL rapid release, but only managed to throw them back up. She went to sleep and by about midnight she was feeling mostly better, with only a slight headache and tired feeling lingering. She felt fatigued and had some minor joint pain at the time of the report. The clinical outcome of the events stiff neck, migraine, vomiting and shaky feelings were recovering; tired and headache was not recovered and the outcome of joint pain was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Nervousness, Vomiting
Clinical narrative: Tired feeling; Joint pain; Vomiting; Shaky feeling; Migraine; Stiff neck; Slight headache; This is a spontaneous report received from a contactable healthcare professional, the patient. A 42-year-old non pregnant female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via an unspecified route of administration in the left arm on 17Mar2021 at 14:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines, hypothyroidism, tension headache (on 16Mar2021) and allergic to mold. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included SYNTHROID, ZYRTEC and MIDNITES, all for an unspecified indication, initiated on unknown date. The patient previously received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the left arm on 24Feb2021 at 14:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient previously took aspirin and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021, immediately after the vaccination, the patient experienced a bit of a stiff neck and still had a slight headache. Over the course of about 5 hours at 19:00, the headache turned into a migraine with splitting head pain, shaky feeling and vomiting. The patient was self-treated with two TYLENOL rapid release, but only managed to throw them back up. She went to sleep and by about midnight she was feeling mostly better, with only a slight headache and tired feeling lingering. She felt fatigued and had some minor joint pain at the time of the report. The clinical outcome of the events stiff neck, migraine, vomiting and shaky feelings were recovering; tired and headache was not recovered and the outcome of joint pain was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Polymenorrhoea
Clinical narrative: My monthly menstrual cycle is always on time and it arrived 6.5 days early; Stomach cramps; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6202) via an unspecified route of administration in the left arm on 09Mar2021 at 09:45 (age the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, heart murmur, full thyroidectomy and low back pain. Allergies to medications, food, or other products was reported to apples, MRI contrast dye. Concomitant medications included levothyroxine (SYNTHROID), ibuprofen (ADVIL) and albuterol (MANUFACTURER UNKNOWN), all for an unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Mar2021, at 14:00, the patient's menstrual cycle (which was always on time) had arrived 6.5 days earlier with severe stomach cramps (the patient would usually get only lower back pain). The patient did not receive treatment for the reported events. The clinical outcome of menstrual cycle shortened and stomach cramps was unknown.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Tiredness; Slightly feverish; This is a spontaneous report received from a non-contactable consumer, the patient. A male (adult) patient of unknown age received unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EL3247) via unspecified route of administration on an unknown date (at an unknown age) as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 17Mar2021, the patient experienced tiredness and was slightly feverish. No therapeutic measures were taken for the events. The clinical outcome of the events tiredness and slightly feverish was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Exposure to SARS-CoV-2, Nausea, SARS-CoV-2 antibody test
Clinical narrative: exposed to covid; nausea; loose stool; This is a spontaneous report from a contactable Other-HCP (patient). A 41-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9263), via an unspecified route of administration, administered in arm left on 26Feb2021 at 09:30 (at the age of 41-years-old) as 1st dose, single for COVID-19 immunization. Medical history was not reported. No known allergies were reported. Patient did not have COVID-19 prior vaccination. Concomitant medications included Vitamin D Nos (VITAMIN D NOS), biotin (BIOTIN), cetirizine hydrochloride (ZIRTEC) and Collegan. On 26Feb2021, the patient experienced exposed to COVID (that evening) and tested positive for COVID on 02Mar2021, GI symptom only, nausea and loose stool. Patient did not receive treatment for the events. Patient received second dose of bnt162b2 on 19Mar2021. On 02Mar2021, the patient underwent lab tests and procedures which included Nasal swab test resulted positive. The outcome of event was recovered on an unspecified date in 2021.   No follow up attempts are possible. no further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: Vision changed can not see well with glasses on. If I remove my glasses my vision is better.; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unknown route of administration in the right arm (at the age of 53-year-old), as a single dose on 18Mar2021 at 07:30 for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was allergic to codeine. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 18Mar2021 at 11:00, the patient vision had changed, could not see well with glasses on and the vision was better if glasses removed. The patient cleaned and checked glasses. No therapeutic measures were taken for the event. The clinical outcome of the event was reported as not recovered.   Information about lot number cannot be obtained. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia
Clinical narrative: Fever of 100.4; Chills; Headache; This is a spontaneous report received from a contactable consumer, the patient. A 61-years-old non-pregnant female patient received first dose of BNT162B2 (COVID-19 MRNA VACCINE BIONTECH; lot number: EN6207) via an unspecified route of administration in the left arm on 16Mar2021 at 16:45 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. The patient's medical history included high blood pressure and high cholesterol. The patient was allergic to codeine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. the concomitant medications included Pravastatin (MANUFATURER UNKNOWN), Hydrochlorothiazide (MANUFACTURER UNKNOWN), Olmesartan (MANUFACTURER UNKNOWN). On 17Mar2021, at 16:45, the patient experienced fever of 100.4 (unspecified units), chills and headache. The patient received ASPIRIN as a treatment for the adverse events. The clinical outcome of the events fever 100.4, chills and headache were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.